Transforming lives with the power of regenerative medicine

Sahaj Regenerative Cell Therapeutics, a healthcare company founded to provide leading global technology with technological collaboration with the leading companies in the field of advanced cell research.

Sahaj Therapy®is a pioneering cell-based therapy that was developed through a collaboration between Cell Innovation, Australia, and Adinizer Bio Solution Leaders (BSL), Korea. It is the first treatment of its kind that uses a patented SVF technology to target the root cause of arthritis, providing relief from joint pain while also supporting joint preservation and cartilage regeneration. It is a unique treatment for knee pain which is based on the human body’s self-healing potential.

'Regenerate', Not Replace.

Patented Technology

SAHAJ THERAPY

- Autologous SVF (Cellular Fraction)

Cutting-edge SVF technology
for treating Joint Pain

A single-window solution for treating joint pain and uses evidence-based
autologous grafting in same surgical sitting by an orthopedic surgeon.
It provides biological solution for biological problem.
This is why SVF an
Ideal Choice:
  • Use of only natural regenerative cells
  • Minimally invasive procedure
  • Performed under local Anesthesia
  • No use of enzymes, chemicals or animal products
  • Only single sitting required
  • No bone loss
  • No risk of infection
  • No need for dramatic lifestyle changes
SVF is
suitable for:
  • For all those who have joint pain.
  • In the case of grades 1, 2, 3 of Osteoarthritis where the joint is stable and the deformity is less than 10°.
  • Suitable for all body weights and age groups above 21 years.
SVF is not
suitable for:
  • Patients having active or latent infection
  • Patients with Gout or Pseudogout
  • HIV patients
  • Patients having active cancer from past 3 years
  • Pregnant and lactating women